日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phosphodiesterase 9 inhibition prolongs the antiparkinsonian action of l-DOPA in parkinsonian non-human primates

磷酸二酯酶 9 抑制剂可延长左旋多巴在患有帕金森病的非人灵长类动物中的抗帕金森病作用

Masilamoni, Gunasingh J; Sinon, Christopher G; Kochoian, Brik A; Singh, Arun; McRiner, Andrew J; Leventhal, Liza; Papa, Stella M

Metabotropic glutamate receptors: targets for neuroprotective therapies in Parkinson disease

代谢型谷氨酸受体:帕金森病神经保护疗法的靶点

Masilamoni, Gunasingh J; Smith, Yoland

Effects of a novel phosphodiesterase 10A inhibitor in non-human primates: A therapeutic approach for schizophrenia with improved side effect profile

新型磷酸二酯酶10A抑制剂在非人灵长类动物中的作用:一种副作用更小的精神分裂症治疗方法

Masilamoni, Gunasingh J; Uthayathas, Subramanian; Koenig, Gerhard; Leventhal, Liza; Papa, Stella M

Phosphodiesterase 10A inhibitor MP-10 effects in primates: comparison with risperidone and mechanistic implications

磷酸二酯酶10A抑制剂MP-10在灵长类动物中的作用:与利培酮的比较及其机制意义

Uthayathas, Subramaniam; Masilamoni, Gunasingh J; Shaffer, Christopher L; Schmidt, Christopher J; Menniti, Frank S; Papa, Stella M

Extrastriatal D2-like receptors modulate basal ganglia pathways in normal and Parkinsonian monkeys

纹状体外 D2 样受体调节正常和帕金森病猴的基底神经节通路

Arash Hadipour-Niktarash, Karen S Rommelfanger, Gunasingh J Masilamoni, Yoland Smith, Thomas Wichmann

Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys

代谢型谷氨酸受体 5 拮抗剂可保护接受 MPTP 治疗的猴子的多巴胺能和去甲肾上腺素能神经元免于退化

Gunasingh J Masilamoni, James W Bogenpohl, David Alagille, Kristen Delevich, Gilles Tamagnan, John R Votaw, Thomas Wichmann, Yoland Smith